Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancerXiu-Zhi Zhu, Zhonghua Wang|Journal of Experimental & Clinical Cancer Research|2021Cited by 89
Efficacy and Mechanism of the Combination of PARP and CDK4/6 Inhibitors in the Treatment of Triple-negative Breast CancerXiu-Zhi Zhu, Zhonghua Wang|Research Square|2020Cited by 0